BioSpace News Archive

Drug Development

IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free Survival

IMV Inc. announced that investigators shared new positive data for its DeCidE1 clinical trial at the 2019 American Society for Clinical Oncology Annual Meeting.

June 1, 2019
·
7 min read
Drug Development

Rakuten Medical Releases Phase 2a Study Data during ASCO Annual Meeting Highlighting Positive Safety Profile and Clinically Meaningful Anti-tumor Activity

Rakuten Medical announces positive data results from its Phase 2a study, evaluating the safety and anti-tumor activity of RM-1929 PIT in patients with locoregional, recurrent head and neck squamous cell carcinoma.

June 1, 2019
·
6 min read
Drug Development

Positive results of lurbinectedin Phase II trial (PharmaMar) for the treatment of relapsed small cell lung cancer are presented at ASCO

The results of PharmaMar’s (MSE: PHM) Phase II study with lurbinectedin as a single agent for the treatment of relapsed small cell lung cancer were presented to the American Society of Clinical Oncology (ASCO) conference, which is currently being held in Chicago.

June 1, 2019
·
5 min read
Drug Development

ALX Oncology Presents New Data from Fully Enrolled ALX148 Clinical Trial Combination Cohorts for the Treatment of Patients with Advanced Solid Tumors

New Clinical Data Presented at the 2019 American Society of Clinical Oncology in Chicago, IL

June 1, 2019
·
3 min read
Drug Development

Daiichi Sankyo’s Pexidartinib Demonstrated Further Improvement with Continued Treatment of Tenosynovial Giant Cell Tumor Patients in New Long-Term Analysis Presented at 2019 ASCO Annual Meeting

Daiichi Sankyo Company, Limited announced that new data from a pooled analysis of the phase 3 ENLIVEN study and phase 1 extension study showed continued treatment with pexidartinib resulted in an increased tumor response rate in TGCT patients.

June 1, 2019
·
10 min read
Biotech Beach

MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer Patients at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

Statistically significant biologic anti-tumor activity demonstrated as measured by a reduction in Ki67 in patients treated with ME-344 compared to an increase in patients receiving placebo

June 1, 2019
·
6 min read
Business

BioGENEius Challenge Announces 2019 Mentor of the Year Awardee

The Biotechnology Institute announced the winner of the Mentor of the Year Award, who will be recognized next week at the 2019 BIO International Convention in Philadelphia.

June 1, 2019
·
3 min read
Policy

Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis

Veracyte, Inc. announced new data demonstrating the potential for its Afirma® Xpression Atlas (XA) genomic test to guide targeted treatment selection for patients with a rare but aggressive form of thyroid cancer concurrent with diagnosis by the company’s Afirma Genomic Sequencing Classifier (GSC).

June 1, 2019
·
6 min read
Business

Patients at St. Joseph’s Children’s Hospital in Tampa Get a Prom of their Very Own

Joseph’s Children’s Hospital hosted prom night for patients who were unable to attend their own dance due to hospitalization or who, due to chronic or life-threatening conditions, may never get the opportunity.

June 1, 2019
·
2 min read
Genetown

Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib

Blueprint Medicines Corporation announced data from the registration-enabling NAVIGATOR trial of avapritinib in patients with PDGFRA Exon 18 mutant gastrointestinal stromal tumors and fourth-line GIST.

June 1, 2019
·
13 min read